 HOUSTON, Oct. 05, 2021 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc. Nasdaq: SLRX, a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present virtually at the 2021 BioFuture Conference. The event will be held in New York City on October 5-6, 2021, at Cure, Deerfield Management Companys vertical healthcare-dedicated innovation campus, with a virtual attendance option. Mr. Arthurs virtual presentation can be accessed via the conferences virtual platform by registered conference attendees. A complimentary registration is available to qualified investors and research analysts. 